These results argue that STIM2, presumably through regulating basal cytosolic Ca2+ levels, activates NFAT1, which in turn induces TGF-β1 expression to promote EMT and enhance cell migration and metastasis of breast cancer cells. This evidence concerns the gene STIM2 and breast carcinoma.